Please provide your email address to receive an email when new articles are posted on . There is no neonatal benefit or harm when using tocolytic drugs for threatened premature birth after 30 weeks’ ...

In honor of Women’s Health Month, reproductive health researcher and Assistant Professor Scott Barnett from the Department of Biochemistry & Molecular Biology shares the sobering reality of the rising ...

Preterm labor doesn't always mean early delivery. About 30% of women who go into labor early still give birth at full term. Knowing the signs matters. Watch for symptoms like regular contractions, ...

A research team at the Medical University of South Carolina reports in Cells that the complement system, part of the body's natural immune defenses, is a key driver of inflammatory responses that ...

New research shows that Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when administered after the onset of preterm labor in a preclinical mouse model.

(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) Mary Scourboutakos, Eastern Virginia Medical School (THE CONVERSATION) Most prenatal ...

February 17, 2011 (UPDATED February 27, 2011)— Clinicians should not use injectable terbutaline to prevent preterm labor or treat it beyond 48 to 72 hours because of the risk for maternal heart ...

WASHINGTON -- The high rate of premature births in the United States constitutes a public health concern that costs society at least $26 billion a year, according to a new report from the Institute of ...

This story has been updated from the original, first published in April, to reflect the students' continuing success in competition. A trio of engineering students is a national finalist of the ...

New research shows that Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when administered after the onset of preterm labor in a preclinical mouse model.